Sulfasalazine | Anti-inflammatory / antibiotic
NMR (Conforms)
Available Options
| Size : | Price | Quantity | |
|---|---|---|---|
| 250 mg | $20.00 | ||
| 1 gram | $30.00 |
Sulfasalazine (599-79-1) is an approved drug with diverse potential applications. Sulfasalzine is a clinically useful agent for the treatment of colitis and ileocolitis.1 It is metabolized by intestinal bacteria to release the anti-inflammatory agent 5-aminosalicylic acid and the antibacterial agent sulfapyridine. It has also been found to be a specific inhibitor of NFκB (IC50 = 500 μM)2, inhibitor of IL-2 production of activated T lymphocytes3 and, TNFα and IL-1 synthesis in macrophages4. Sulfasalazine has more recently been shown to be inhibitor of the system Xc- cystine-glutamate antiporter.5,6 It was able to block cystine uptake causing depletion of glutathione resulting in compromised cellular redox defense and ultimately cessation of tumor growth. It has been studied for the treatment of breast, pancreatic, lymphoma, brain and other cancers.
References/Citations:
1) Peppercorn (1984), Sulfasalazine. Pharmacology, clinical use, toxicity, and related drug development; Ann. Intern. Med., 101 377
2) Wahl et al. (1998), Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B; J. Clin. Invest., 101 1163
3) Sheldon et al. (1988), Effect of sulphasalazine and its metabolites on mitogen induced transformation of lymphocytes Ð clues to its clinical action?; Br. J. Rheumatol., 27 344
4) Fujiwara et al. (1990), Inhibition of proliferation responses and interleukin 2 production by salazosulfapyridine and its metabolites; Jpn. J. Pharmacol., 54 121
5) Chung and Sontheimer (2009), Sulfasalazine inhibits the growth of primary brain tumors in dependent of nuclear factor-κB; J.Neurochem., 110 182
6) Patel et al. (2004), Differentiation of substrate and non-substrate inhibitors of transport system Xc – :an obligate exchanger of L-glutamate and L-cystine; Neuropharmacol., 46 273
NMR (Conforms)
Safety Data Sheet:
Product Data Sheet:
Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee
Sulfasalazine (599-79-1) is an approved drug with diverse potential applications. Sulfasalzine is a clinically useful agent for the treatment of colitis and ileocolitis.1 It is metabolized by intestinal bacteria to release the anti-inflammatory agent 5-aminosalicylic acid and the antibacterial agent sulfapyridine. It has also been found to be a specific inhibitor of NFκB (IC50 = 500 μM)2, inhibitor of IL-2 production of activated T lymphocytes3 and, TNFα and IL-1 synthesis in macrophages4. Sulfasalazine has more recently been shown to be inhibitor of the system Xc- cystine-glutamate antiporter.5,6 It was able to block cystine uptake causing depletion of glutathione resulting in compromised cellular redox defense and ultimately cessation of tumor growth. It has been studied for the treatment of breast, pancreatic, lymphoma, brain and other cancers.
References/Citations:
1) Peppercorn (1984), Sulfasalazine. Pharmacology, clinical use, toxicity, and related drug development; Ann. Intern. Med., 101 377
2) Wahl et al. (1998), Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B; J. Clin. Invest., 101 1163
3) Sheldon et al. (1988), Effect of sulphasalazine and its metabolites on mitogen induced transformation of lymphocytes Ð clues to its clinical action?; Br. J. Rheumatol., 27 344
4) Fujiwara et al. (1990), Inhibition of proliferation responses and interleukin 2 production by salazosulfapyridine and its metabolites; Jpn. J. Pharmacol., 54 121
5) Chung and Sontheimer (2009), Sulfasalazine inhibits the growth of primary brain tumors in dependent of nuclear factor-κB; J.Neurochem., 110 182
6) Patel et al. (2004), Differentiation of substrate and non-substrate inhibitors of transport system Xc – :an obligate exchanger of L-glutamate and L-cystine; Neuropharmacol., 46 273
Related products
-
IMP-1700 | Bacterial DNA repair inhibitor
From $60.00CAS:1458674-25-3Catalog Number:10-3950Activity:Bacterial DNA repair inhibitorChemical Name:1-Cyclopropyl-6-fluoro-4-oxo-7-(4-(4-(trifluoromethyl)phenyl)carbamothioyl)piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acidMolecular Weight:534.53Molecular Formula:C25H22F4N4O5SSolubility:Soluble in DMSO (up to 25 mg/ml).Physical Properties:White solidPurity:98% by TLC
NMR (Conforms)Storage Temperature:-20°Stability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 1 month.Shipping Code:RT -
Tropodithietic acid | Cytotoxic disulfide antibiotic
From $150.00CAS:750590-18-2Catalog Number:10-3307Activity:Cytotoxic disulfide antibioticChemical Name:Oxo-8,9-dithiabicyclo[5.2.0]non-1,4,6-triene-2-carboxylic acidMolecular Weight:212.25Molecular Formula:C8H4O3S2Solubility:Soluble in DMSO (up to 5 mg/ml)Physical Properties:Orange solidPurity:98% by HPLC
NMR (Conforms)Storage Temperature:-20°CStability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.Shipping Code:RT -
MAC-545496 | GraR inhibitor
From $60.00CAS:838810-96-1Catalog Number:10-3951Activity:GraR inhibitorChemical Names:N-[(5-Chloropyridin-2-yl)carbamothioyl]-3-nitro-4-piperidin-1-ylbenzamideMolecular Weight:419.88Molecular Formula:C18H18ClN5O3SSolubility:Soluble in DMSO (25 mg/ml)Physical Properties:Yellow/orange solidPurity:98% TLC
NMR (Conforms)Storage Temperature:-20°CStability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 monthShipping Code:RT
Calculate the molar concentration, mass or volume in a solution.
Concentration × Volume × Molecular Weight = Mass
20% OFF
For Postdoc
Customers!
Focus Biomolecules • Plymouth Meeting, PA USA • 1-855-FOCUS21
Focus Biomolecules
Plymouth Meeting, PA USA
1-855-FOCUS21
Website Created by Advanta Advertising LLC.